驗證網址www.ncbi.nlm.nih.gov安全性

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients wit

1. J Clin Oncol. 2013 Mar 20;31(9):1157-63. doi: 10.1200/JCO.2012.44.9694. Epub 2013 Feb 4. Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic ...

網址安全性掃描由 google 提供